Emergent BioSolutions Inc.
NYSE · Healthcare · Pharmaceutical Preparations · Gaithersburg, MD
EBS chart
What traders are saying about $EBS
Latest postsEmergent BioSolutions Inc. news
- Swedish Orphan Biovitrum (BIOVF) Tops Q3 Earnings and Revenue Estimates
Yahoo Finance ·
- India's VC Funding Remains Flat, Focus Shifts to Deeptech
Rediff ·
- Trading Systems Reacting to (EBS) Volatility
Stock Traders Daily ·
- Emergent Biosolutions Stock Price Forecast. Should You Buy EBS?
StockInvest.us ·
- Emergent BioSolutions Inc. Estimates – NYSE:EBS
TradingView ·
- Emergent BioSolutions Inc. (0IGA.L) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Emergent BioSolutions CFO Richard Lindahl to Retire
BioBuzz ·
- Emergent BioSolutions stock falls as CFO plans retirement
Yahoo Finance ·
- Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl
Yahoo Finance ·
- Bioscience Association Manitoba Welcomes New Board Members and Executive Members at Annual General Meeting
Yahoo Finance ·
- Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026
Yahoo Finance ·
- Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock?
Yahoo Finance ·
Emergent BioSolutions Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $742.9M | $1.04B | $1.05B | – |
| Net income | $52.6M | -$190.6M | -$760.5M | -$211.6M |
| Diluted EPS | $0.93 | $-3.60 | $-14.85 | $-4.22 |
| Total assets (year end) | $1.32B | $1.39B | $1.82B | $3.17B |
| Cash and equivalents (year end) | $205.4M | $99.5M | $111.7M | $642.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Emergent BioSolutions Inc.
- Ticker
- EBS (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Gaithersburg, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1367644
Frequently asked questions
What exchange is Emergent BioSolutions Inc. listed on?
Emergent BioSolutions Inc. trades on the NYSE under the ticker symbol EBS.
What industry is Emergent BioSolutions Inc. in?
Emergent BioSolutions Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Emergent BioSolutions Inc. headquartered?
Emergent BioSolutions Inc.'s business address on file with the SEC is in Gaithersburg, MD.
When does Emergent BioSolutions Inc.'s fiscal year end?
Emergent BioSolutions Inc.'s fiscal year ends on December 31.
How much revenue did Emergent BioSolutions Inc. report?
Emergent BioSolutions Inc. reported $742.9M in revenue for calendar year 2025, according to its SEC filings.